Fig. 7.

Coversin did not significantly decrease plasma markers of myocardial ischemia. Troponin T (a) and H-FABP (b) were detected in plasma throughout the study period. Myocardial ischemia lead to an increase in troponin T and H-FABP in both control (open boxes) and coversin treated (filled circles). Coversin treated animals showed a trend towards lower H-FABP levels throughout the whole reperfusion period without reaching significance in comparison to control animals (troponin T: p = 0.39; H-FABP: p = 0.07). Values presented as mean ± SEM [n = 8 (placebo) and n = 7 (coversin)]. Linear mixed effect model